about
A Review of Computational Methods for Finding Non-Coding RNA GenesPOSTAR: a platform for exploring post-transcriptional regulation coordinated by RNA-binding proteinsNeuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Enhancers and chromatin structures: regulatory hubs in gene expression and diseases.Functional assessment of CTCF sites at cytokine-sensing mammary enhancers using CRISPR/Cas9 gene editing in miceTranscriptomics technologies.Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.The origin of B chromosomes in yellow-necked mice (Apodemus flavicollis)-Break rules but keep playing the game.In silico prediction of lncRNA function using tissue specific and evolutionary conserved expression.Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signatureExome-based Variant Detection in Core PromotersiRegNet3D: three-dimensional integrated regulatory network for the genomic analysis of coding and non-coding disease mutations.Epigenetic and genetic dissections of UV-induced global gene dysregulation in skin cells through multi-omics analysesIdentification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networksIntegrative whole-genome sequence analysis reveals roles of regulatory mutations in BCL6 and BCL2 in follicular lymphomaInherited determinants of early recurrent somatic mutations in prostate cancer.Perspectives of long non-coding RNAs in cancer.Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma.Using FunSeq2 for Coding and Non-Coding Variant Annotation and Prioritization.Enhancer deregulation in cancer and other diseases.Altered TERT promoter and other genomic regulatory elements: occurrence and impact.The present and future of genome editing in cancer research.Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer.Polymorphisms in Non-coding RNA Genes and Their Targets Sites as Risk Factors of Sporadic Colorectal Cancer.The pleiotropic role of non-coding genes in development and cancer.Functional variomics and network perturbation: connecting genotype to phenotype in cancer.Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients.APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALLNon-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate.Identification of breast cancer associated variants that modulate transcription factor binding.A method to reduce ancestry related germline false positives in tumor only somatic variant calling.MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer.Predicting cancer type from tumour DNA signatures.Human gene essentiality.Making the cut in the dark genome.CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
P2860
Q28066471-C896C014-78C7-470F-869A-065AD7562F23Q28584439-645D0E86-4EE4-4819-A126-6BF13DE9C65BQ30239861-4B499D90-95A8-495E-A19D-A100FC3AC081Q30244282-C8F4CD43-C9E9-43FA-8AC7-9730D57A3947Q30245184-B0DF610F-7365-4B32-808C-715752866DD2Q33613467-55D2BEA8-BD48-4B3E-A971-5DE7C520D121Q33635936-483E9BEC-3B29-4BE2-9989-426C31D31CB4Q33703532-6F2F43A0-00CE-485C-8437-5BBB1AB31E42Q34529131-7607AC4C-AEE9-47EA-913D-D0391FEFD1ABQ36311118-98B790A2-85F2-41AD-8074-AD58296A4F7BQ36318528-0DE37A1B-211B-4E4D-92A5-4417140A8D38Q36329484-6E4B565E-F15F-4084-BA59-E35AA3617971Q36367931-6CAB28B5-9C48-4F3D-92C8-AE60F7B2EF60Q37134875-CFDE3DAF-EEF8-4C24-AFB0-4AD9844A8A2FQ37591538-F0FA7FDD-95B0-4455-9348-C2CBF2DBED92Q37648488-B72C5FD8-7B2C-4F6A-9123-37E8D5535068Q38601823-DE9AB3A7-9237-45D4-8149-4C4BFD1ECCAFQ38647938-F2A8980F-6C12-438F-BD22-46932AB2DF86Q38701501-3E0C113A-79A8-4356-8BD8-058A75B29AE8Q38732979-BC4331A4-8A97-40A7-90EC-17784F761F18Q38743243-9F294933-B5CA-4F3D-B735-7466508D7C06Q38809250-C82F3CEC-4E53-4762-972F-CBD13DEBDB9FQ38826989-03800689-94B1-4B58-8E26-95710A53A3ECQ38838144-A48E692A-73C1-4006-B178-D47B47DF3CFFQ38840267-7237629E-C1EB-466F-BC80-315CF28FF1CEQ38888022-FBEAD100-3654-47C7-AB0C-CACDD60AD706Q38940602-0F0E8977-0956-4D1F-AFB5-250E9C68B65BQ39013954-01EABC48-479F-4068-B86F-497C5528B445Q39201399-9600B8ED-DF49-4FA9-A906-D8F531B23FA8Q40378252-8B80DCCF-C66E-48FE-A4D8-DD703D5B941FQ41436597-25D8625E-13F5-4D23-B3D2-A77B27C7EB63Q41932009-0E77305A-323B-4308-86A3-8DC20F6F9E09Q42251890-727EC1D8-B08F-4E8D-97F0-B30C78345580Q42366138-165B9F3C-E8C6-477E-878B-6D110222A7A8Q42669039-A78A1639-79CA-4149-8038-B89276E405B0Q42682692-D35F8C18-A08F-4236-8399-650F563A6F2AQ45943506-88EB68B2-86A3-4DF1-B83B-47F3C293D88CQ46065137-A6AAC733-F62F-4349-B396-4D7CD7162C65Q46103297-D3566670-81AF-43D9-BB0B-1CD89BEFC4BEQ46522290-44FC83B5-F1D4-448C-8660-A89FBB5D0460
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Role of non-coding sequence variants in cancer.
@ast
Role of non-coding sequence variants in cancer.
@en
Role of non-coding sequence variants in cancer.
@nl
type
label
Role of non-coding sequence variants in cancer.
@ast
Role of non-coding sequence variants in cancer.
@en
Role of non-coding sequence variants in cancer.
@nl
prefLabel
Role of non-coding sequence variants in cancer.
@ast
Role of non-coding sequence variants in cancer.
@en
Role of non-coding sequence variants in cancer.
@nl
P2093
P2860
P356
P1476
Role of non-coding sequence variants in cancer.
@en
P2093
Dimple Chakravarty
Ekta Khurana
Francesca Demichelis
P2860
P2888
P304
P356
10.1038/NRG.2015.17
P577
2016-01-19T00:00:00Z
P6179
1053266182